BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7455697)

  • 1. Specific and sensitive radioimmunoassay for 3-methoxy-4-hydroxyphenylethyleneglycol (MOPEG).
    Keeton TK; Krutzsch H; Lovenberg W
    Science; 1981 Feb; 211(4482):586-8. PubMed ID: 7455697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of normetanephrine, 3,4-dihydroxyphenylethyleneglycol (free and total), and 3-methoxy-4-hydroxyphenylethyleneglycol (free and total) in rat brain by high-performance liquid chromatography with electrochemical detection and effects of drugs on regional concentrations.
    Westerink BH
    J Neurochem; 1984 Apr; 42(4):934-42. PubMed ID: 6699645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A method for the assay of conjugated 3,4-dihydroxyphenylglycol, a major noradrenaline metabolite in the rat brain.
    Nielsen M; Braestrup C
    J Neurochem; 1976 Nov; 27(5):1211-7. PubMed ID: 12170609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra- and extraneuronal formation of the two major noradrenaline metabolites in the cns of rats.
    Braestrup C; Nielsen M
    J Pharm Pharmacol; 1975 Jun; 27(6):413-9. PubMed ID: 237089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of amphetamine and fenfluramine on brain noradrenaline and MOPEG-SO4.
    Calderini G; Morselli PL; Garattini S
    Eur J Pharmacol; 1975 Dec; 34(2):345-50. PubMed ID: 1234553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of noradrenaline and 3-methoxy-4-hydroxyphenylethyleneglycol sulfate in discrete brain regions of the rat.
    Kohno Y; Matsuo K; Tanaka M; Furukawa T; Nagasaki N
    Anal Biochem; 1979 Sep; 97(2):352-8. PubMed ID: 525798
    [No Abstract]   [Full Text] [Related]  

  • 7. Developmental difference in noradrenaline and 3-methoxy-4-hydroxyphenylethyleneglycol sulfate (MHPG-SO4) levels in rat whole brain.
    Kohno Y; Tanaka M; Nakagawa R; Ida Y; Iimori K; Nagasaki N
    Kurume Med J; 1981; 28(1):95-8. PubMed ID: 7321520
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of propranolol on blood pressure and central MOPEG concentration in the conscious spontaneously hypertensive rat.
    Keeton TK; Hall JS
    Eur J Pharmacol; 1986 Jun; 125(2):293-6. PubMed ID: 3743639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of piribedil on noradrenaline and MOPEG-SO4 levels in the rat brain.
    Garattini S; Bareggi SR; Marc V; Calderini G; Morselli PL
    Eur J Pharmacol; 1974 Sep; 28(1):214-6. PubMed ID: 4430323
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical conditions and concentrations of MOPEG in the cerebrospinal fluid and urine of male alcoholic patients during withdrawal.
    Borg S; Czarnecka A; Kvande H; Mossberg D; Sedvall G
    Alcohol Clin Exp Res; 1983; 7(4):411-5. PubMed ID: 6362467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased brain norepinephrine metabolism correlated with analgesia produced by the periaqueductal gray injection of opiates.
    Reigle TG
    Brain Res; 1985 Jul; 338(1):155-9. PubMed ID: 4027585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma 3,4-dihydroxyphenylethyleneglycol and 3-methoxy-4-hydroxyphenylethyleneglycol as indicators of central noradrenergic activity. A comparative study on control subjects and depressed patients.
    Azorin JM; Karege F; Valli M; Pringuey D; Joanny P; Tissot R
    Neuropsychobiology; 1988; 20(2):67-73. PubMed ID: 3075724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of free and conjugated 3-methoxy-4-hydroxyphenylglycol (MOPEG) in rat brain by gas chromatography and mass fragmentography.
    Braestrup C
    Anal Biochem; 1973 Oct; 55(2):420-31. PubMed ID: 4750684
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of single and multiple doses of desipramine (DMI) on endogenous levels of 3-methoxy-4-hydroxyphenylglycol-sulfate (MOPEG-SO4) in rat brain.
    Bareggi SR; Markey K; Genovese E
    Eur J Pharmacol; 1978 Aug; 50(4):301-6. PubMed ID: 699958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physiological role and clinical significance of 3-methoxy-4-hydroxyethyleneglycol, a noradrenaline metabolite (review of the literature)].
    Bol'shakova TD; Shenderovich MIa
    Vopr Med Khim; 1987; 33(6):3-11. PubMed ID: 3328414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short and long-term effects of reserpine on the concentration of 1-(4-hydroxy-3-methoxyphenyl)-ethane-1,2-diol (MOPEG-SO4) in the brain of the rat.
    Bareggi SR; Genovese E; Markey K
    Br J Pharmacol; 1979 Apr; 65(4):573-8. PubMed ID: 435682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of several narcotic analgesics on brain levels of 3-methoxy-4-hydroxyphenylethylene glycol sulfate in the rat.
    LoPachin RM; Reigle TG
    J Pharmacol Exp Ther; 1978 Oct; 207(1):151-8. PubMed ID: 29961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Methoxy-4-hydroxyphenylglycol sulphate (MOPEG-SO4) as an index of cerebral noradrenaline turnover following depletion of transmitter stores in the rat.
    Dolphin A; Jenner P; Marsden CD
    J Pharm Pharmacol; 1978 Sep; 30(9):580-2. PubMed ID: 29100
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of phenoxybenzamine, aceperone and clonidine on the level of 3-methoxy-4-hydroxyphenylglycol (MOPEG) in rat brain.
    Braestrup C
    J Pharm Pharmacol; 1974 Feb; 26(2):139-41. PubMed ID: 4150833
    [No Abstract]   [Full Text] [Related]  

  • 20. Is 3,4-dihydroxyphenylglycol the major route of central norepinephrine metabolism in rat brain?
    Karege F; Gaillard JM
    Neurosci Lett; 1986 Aug; 69(1):78-83. PubMed ID: 3748468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.